• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

米诺环素联合药物治疗强迫症：一项开放标签试验。

Minocycline augmentation of pharmacotherapy in obsessive-compulsive disorder: an open-label trial.

出版信息

J Clin Psychiatry. 2010 Sep;71(9):1247-9. doi: 10.4088/JCP.09l05805blu.

DOI:10.4088/JCP.09l05805blu
PMID:20923629
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3923525/
Abstract

not applicable, since submission is “letter to the editor.”

摘要

不适用，因为提交的是“给编辑的信”。

相似文献

1
Minocycline augmentation of pharmacotherapy in obsessive-compulsive disorder: an open-label trial.米诺环素联合药物治疗强迫症：一项开放标签试验。
J Clin Psychiatry. 2010 Sep;71(9):1247-9. doi: 10.4088/JCP.09l05805blu.
2
Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series.在对选择性5-羟色胺再摄取抑制剂难治的强迫症中加用奥氮平：一项开放标签病例系列研究
J Clin Psychiatry. 1999 Aug;60(8):524-7. doi: 10.4088/jcp.v60n0804.
3
Case series: Adderall augmentation of serotonin reuptake inhibitors in childhood-onset obsessive compulsive disorder.
J Child Adolesc Psychopharmacol. 2002 Summer;12(2):165-71. doi: 10.1089/104454602760219207.
4
Effect of Ziprasidone Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: A 12-Week, Open-Label Uncontrolled Preliminary Study.齐拉西酮增强5-羟色胺再摄取抑制剂治疗难治性强迫症的效果：一项为期12周的开放标签非对照初步研究。
Clin Neuropharmacol. 2016 Jan-Feb;39(1):6-9. doi: 10.1097/WNF.0000000000000123.
5
Minocycline combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trial.米诺环素联合氟伏沙明治疗中重度强迫症的安慰剂对照、双盲、随机试验。
Psychiatry Clin Neurosci. 2016 Nov;70(11):517-526. doi: 10.1111/pcn.12430. Epub 2016 Sep 29.
6
Early augmentation in the management of obsessive-compulsive disorder.强迫症管理中的早期强化治疗
Asian J Psychiatr. 2022 Mar;69:103005. doi: 10.1016/j.ajp.2022.103005. Epub 2022 Jan 4.
7
Pharmacotherapy of obsessive-compulsive disorder: experience with the selective serotonin reuptake inhibitors.强迫症的药物治疗：选择性5-羟色胺再摄取抑制剂的应用经验
Int Clin Psychopharmacol. 2000 Aug;15 Suppl 2:S7-13. doi: 10.1097/00004850-200008002-00003.
8
Inositol augmentation of serotonin reuptake inhibitors in treatment-refractory obsessive-compulsive disorder: an open trial.肌醇增强5-羟色胺再摄取抑制剂治疗难治性强迫症：一项开放性试验。
Int Clin Psychopharmacol. 1999 Nov;14(6):353-6. doi: 10.1097/00004850-199911000-00005.
9
The future of pharmacotherapy for obsessive-compulsive disorder may lie in a better understanding of its heterogeneity.强迫症药物治疗的未来可能在于更好地理解其异质性。
Expert Opin Pharmacother. 2014 Jul;15(10):1321-3. doi: 10.1517/14656566.2014.924506. Epub 2014 May 28.
10
Diagnosis and treatment of a patient with both psychotic and obsessive-compulsive symptoms.诊断和治疗同时具有精神病和强迫症症状的患者。
Am J Psychiatry. 2010 Jul;167(7):754-61. doi: 10.1176/appi.ajp.2009.09070997.

引用本文的文献

1
Hereditary Patterns and Genetic Associations in Obsessive-Compulsive Disorder (OCD): Neuropsychiatric Insights, Genetic Influences, and Treatment Perspectives.强迫症（OCD）的遗传模式与基因关联：神经精神学见解、基因影响及治疗前景
Curr Gene Ther. 2025;25(3):257-316. doi: 10.2174/0115665232316708240828063527.
2
Searching for host immune-microbiome mechanisms in obsessive-compulsive disorder: A narrative literature review and future directions.探索强迫症患者宿主免疫-微生物组机制：叙事性文献综述及未来方向
Neurosci Biobehav Rev. 2021 Jun;125:517-534. doi: 10.1016/j.neubiorev.2021.02.034. Epub 2021 Feb 24.
3
Investigational and Experimental Drugs to Treat Obsessive-Compulsive Disorder.用于治疗强迫症的研究性和实验性药物。
J Exp Pharmacol. 2021 Jan 5;12:695-706. doi: 10.2147/JEP.S255375. eCollection 2020.
4
What Does Immunology Have to Do With Normal Brain Development and the Pathophysiology Underlying Tourette Syndrome and Related Neuropsychiatric Disorders?免疫学与正常脑发育以及抽动秽语综合征和相关神经精神障碍背后的病理生理学有何关系？
Front Neurol. 2020 Sep 16;11:567407. doi: 10.3389/fneur.2020.567407. eCollection 2020.
5
Neuroinflammatory alterations in trait anxiety: modulatory effects of minocycline.特质焦虑中的神经炎症改变：米诺环素的调节作用。
Transl Psychiatry. 2020 Jul 30;10(1):256. doi: 10.1038/s41398-020-00942-y.
6
Assessment and Treatment of Anxiety Among Children and Adolescents.儿童和青少年焦虑症的评估与治疗
Focus (Am Psychiatr Publ). 2017 Apr;15(2):144-156. doi: 10.1176/appi.focus.20160047. Epub 2017 Apr 6.
7
Obsessive-Compulsive Disorder: Autoimmunity and Neuroinflammation.强迫症：自身免疫与神经炎症。
Curr Psychiatry Rep. 2019 Aug 1;21(8):78. doi: 10.1007/s11920-019-1062-8.
8
Pharmacotherapy for Hoarding Disorder: How did the Picture Change since its Excision from OCD?囤积障碍的药物治疗：从强迫症中切除后，情况有何变化？
Curr Neuropharmacol. 2019;17(8):808-815. doi: 10.2174/1570159X17666190124153048.
9
Metabolic syndrome-associated cognitive decline in mice: Role of minocycline.小鼠中与代谢综合征相关的认知衰退：米诺环素的作用
Indian J Pharmacol. 2018 Mar-Apr;50(2):61-68. doi: 10.4103/ijp.IJP_110_18.
10
Individualized Immunological Data for Precise Classification of OCD Patients.用于强迫症患者精确分类的个性化免疫数据。
Brain Sci. 2018 Aug 9;8(8):149. doi: 10.3390/brainsci8080149.

本文引用的文献

1
A single-blinded case-control study of memantine in severe obsessive-compulsive disorder.一项关于美金刚治疗严重强迫症的单盲病例对照研究。
J Clin Psychopharmacol. 2010 Feb;30(1):34-9. doi: 10.1097/JCP.0b013e3181c856de.
2
Differential efficacy of memantine for obsessive-compulsive disorder vs. generalized anxiety disorder: an open-label trial.美金刚治疗强迫症与广泛性焦虑症的疗效差异：一项开放标签试验。
Psychopharmacol Bull. 2009;42(1):81-93.
3
Memantine augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial.美金刚增效治疗难治性强迫症：一项开放标签试验。
J Clin Psychopharmacol. 2009 Feb;29(1):51-5. doi: 10.1097/JCP.0b013e318192e9a4.
4
Meta-analysis of the symptom structure of obsessive-compulsive disorder.强迫症症状结构的荟萃分析。
Am J Psychiatry. 2008 Dec;165(12):1532-42. doi: 10.1176/appi.ajp.2008.08020320. Epub 2008 Oct 15.
5
Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder.谷氨酸调节药物作为治疗强迫症的新型药物治疗剂。
NeuroRx. 2006 Jan;3(1):69-81. doi: 10.1016/j.nurx.2005.12.006.
6
Defining response in clinical trials for obsessive-compulsive disorder: a signal detection analysis of the Yale-Brown obsessive compulsive scale.强迫症临床试验中反应的定义：耶鲁-布朗强迫症量表的信号检测分析
J Clin Psychiatry. 2005 Dec;66(12):1549-57. doi: 10.4088/jcp.v66n1209.
7
N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder.N-乙酰半胱氨酸增强疗法治疗5-羟色胺再摄取抑制剂难治性强迫症
Psychopharmacology (Berl). 2006 Jan;184(2):254-6. doi: 10.1007/s00213-005-0246-6. Epub 2005 Dec 22.
8
Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial.利鲁唑辅助治疗难治性强迫症：一项开放标签试验。
Biol Psychiatry. 2005 Sep 1;58(5):424-8. doi: 10.1016/j.biopsych.2005.04.043.
9
Neuroprotection in Huntington's disease: a 2-year study on minocycline.亨廷顿舞蹈病中的神经保护作用：米诺环素的两年研究
Int Clin Psychopharmacol. 2004 Nov;19(6):337-42. doi: 10.1097/00004850-200411000-00004.
10
Viral-induced spinal motor neuron death is non-cell-autonomous and involves glutamate excitotoxicity.病毒诱导的脊髓运动神经元死亡是非细胞自主性的，且涉及谷氨酸兴奋性毒性。
J Neurosci. 2004 Aug 25;24(34):7566-75. doi: 10.1523/JNEUROSCI.2002-04.2004.